#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Lip and/or oral cavity cancer Liposarcoma Neuropathy peripheral Squamous cell carcinoma of head and neck Sjogren's syndrome Leiomyosarcoma metastatic Cardiac failure acute Penile cancer Immune thrombocytopenia Acute graft versus host disease in liver Sarcoidosis Anal cancer recurrent Peripheral T-cell lymphoma unspecified Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Basic Information Choroid melanoma – Treatment Short-bowel syndrome – Diagnostics Langerhans’ cell histiocytosis – Basic Information Haemophilia A without inhibitors – Basic Information Uterine leiomyosarcoma – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Rhabdomyosarcoma recurrent – Trials in Disease Pemphigus – Trials in Disease Ehlers-Danlos syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Normal Immunoglobulin Nortriptyline Gadoxetic Acid, Disodium TEV-53408 Epinephrine Hydrochloride CHLOROQUINE PHOSPHATE Eik1003 PAPAVERINE HYDROCHLORIDE Fentanyl Citrate Egl-001 LUTETIUM LU-177 Vosoritide Nofazinlimab SIGVOTATUG VEDOTIN Gliquidone Ropeginterferon Alfa-2B Defactinib Arbaclofen Fexofenadine Cenerimod More therapies…

    Learn about Your Condition

    Primary myelofibrosis Skin papilloma Nephroblastoma Osteoporosis Vasoplegia syndrome Testis cancer Lower limb fracture Diabetes mellitus Gastrointestinal disorder Lumbosacral radiculopathy Microvillous inclusion disease Systemic mastocytosis Hypertrophic cardiomyopathy Glomerulonephritis Neutropenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Newborn Brain Conditions Using Sulfur Hexafluoride Ultrasound for Babies with Hypoxic-Ischemic Injury, Stroke, or Infections

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Sulfur Hexafluoride
    Finland

  • Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Lenalidomide
    Iceland

  • Study on Stopping Nilotinib for Chronic Myeloid Leukemia Patients After Previous Unsuccessful Attempts to Stop Tyrosine Kinase Inhibitors

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia (in remission)
    Investigated Drugs:
    • Nilotinib
    Germany

  • Study on Allogeneic Faecal Microbiota for Treating Antibiotic-Related Diarrhea in Critically Ill Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diarrhoea
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Czechia

  • Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Alectinib
    Italy

  • Study on Treosulfan and Melphalan for High-Risk Ewing Sarcoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Treosulfan
    • Vinorelbine
    • Ifosfamide
    Italy
Previous Page
1 … 826 827 828 829 830 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!